An automated immunoassay system cuts down the time and sample volume needed to run sequential experiments.

Get up to date on the next generation of rapid, point-of-care diagnostics. 

Experts discuss how to optimize challenging host cell protein assays.  

Researchers detect aberrant cytokine activity in response to SARS-CoV-2 infection.

Discover methods to improve coverage analysis of any cell line.

Improve lateral flow-based immunoassays to detect pathogens and biomarkers more accurately.

Researchers study obesity by assessing ghrelin levels in biological samples.

Immunoassays that measure neopterin in patient samples provide a wealth of information that is useful in the laboratory and the clinic.

A sensitive, automated immunoassay measures neurofilament light from patient blood samples.

Big discoveries come from miniaturized assays

The CRISPR-Cas system, supported by advances in plate reader technology, has transformed drug discovery processes.

A fully electronic pipette improves results by reducing variance and user fatigue.

A magnetic bead-based immunoassay quantifies up to 100 biomarkers per sample.

Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.

Single Molecule Counting (SMC™) technology offers the sensitivity to reveal hidden biomarker information